Effects of Th17 and Treg cells with their balance on thyroid-associated ophthalmopathy
10.3980/j.issn.1672-5123.2022.7.14
- VernacularTitle:Th17和Treg细胞及其平衡对甲状腺相关眼病的影响
- Author:
Ping WANG
1
;
Yu FU
1
;
Min-Min JIANG
1
;
Ze-Jin WANG
1
;
Yan YAN
1
;
Tian-Yu GAO
1
;
Ying WANG
1
;
Shu-Xun YAN
1
Author Information
1. Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
- Publication Type:Journal Article
- Keywords:
T-helper 17 lymphocyte(Th17)cells;
regulatory T(Treg)cells;
thyroid-associated ophthalmopathy
- From:
International Eye Science
2022;22(7):1137-1142
- CountryChina
- Language:Chinese
-
Abstract:
Thyroid-associated ophthalmopathy(TAO)is an organ-specific autoimmune disease, which will cause a series of symptoms to significantly reduce the health level and life quality of patients. The pathogenesis of TAO has not been fully clarified. At present, there is a lack of unified and mature treatment scheme of it. Indeed, T-helper 17 lymphocyte(Th17)cells, regulatory T(Treg)cells and their imbalance are closely related to the immunological pathogenesis of TAO. It is currently believed that the cytokines secreted by Th17 cells can not only promote the inflammatory response of TAO and the fibrosis of orbital connective tissue, but also inhibit the adipogenic differentiation of TAO orbital connective tissue. In addition, Treg cells mainly exert immunosuppressive effect on TAO and delay the disease progression. At the same time, there is a dynamic balance relationship between Th17 and Treg cells, the imbalance of Th17/Treg cells can trigger the occurrence and development of TAO. This paper mainly expounds the influence mechanism of Th17, Treg cells and their balance on TAO, and analyzes the reasons for the differences between different research results, so as to provide some reference for the study of the pathogenesis and clinical treatment of TAO.
